SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 140.16 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 80.68 |
| Book Value / Share | 0.74 |
| Price / Book | n/a |
| NCAV ($M) | 56.10 |
| NCAV / Share | 0.52 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.43 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.19 |
| Current Ratio | 12.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 120.33 |
| Assets | 144.92 |
| Liabilities | 64.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Rubric Capital Management LP | 10.38 | ||
| 13G | Point72 Asset Management, L.P. | 6.40 | ||
| 13G | Suvretta Capital Management, Llc | 5.90 | ||
| 13G/A | Vivo Capital IX, LLC | 8.17 | -70.71 | |
| 13G/A | Boxer Capital, LLC | 9.10 | -49.37 | |
| 13G/A | Citadel Advisors Llc | 8.90 | ||
| 13G | Baker Bros. Advisors Lp | 11.40 | ||
| 13G | Orbimed Advisors Llc | 6.66 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 133,512 | 618,743 | 21.58 | |
| 107,920 | 308,583 | 34.97 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MOLN – Molecular Partners AG | MOR – MorphoSys AG |
| MORF – Morphic Holding Inc | MRKR – Marker Therapeutics Inc |
| MRNA – Moderna Inc |
Financial data and stock pages provided by
Fintel.io
